Rif El-Mallakh

Rif El-Mallakh


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2003 in Bipolar Disorders
Verified
Journal Article
Closed access
PDF file
RERif El-Mallakh
Rif El-Mallakh
MEM Adnan El‐Masri
M Adnan El‐Masri
MHMary O'MAlley Huff
Mary O'MAlley Huff
XLXiao‐Ping Li
Xiao‐Ping Li
SDSarah Decker
Sarah Decker
RLRobert S Levy
Robert S Levy

1 October 2013 in Neurocase
Verified
Journal Article
Closed access
JPJames R. Phelps
James R. Phelps
SSSusan V. Siemers
Susan V. Siemers
RERif El-Mallakh
Rif El-Mallakh
Successful mood stabilizing treatments reduce intracellular sodium in an activity-dependent manner. This can also be achieved with acidification of the blood, as is the case with the ketogenic diet. Two women with type II bipolar disorder were able to maintain ketosis for prolonged periods of time (2 and 3 years, respectively). Both experienced mood stabilization that exceeded that achieved with medication; experienced a significant subjective improvement that was distinctly related to ketosis; and tolerated the diet well. There were no significant adverse effects in either case. These cases demonstrate that the ketogenic diet is a potentially sustainable option for mood stabilization in type II bipolar illness. They also support the hypothesis that acidic plasma may stabilize mood, perhaps by reducing intracellular sodium and calcium.

1 June 2011 in Medical Hypotheses
Verified
Journal Article
Closed access
RERif El-Mallakh
Rif El-Mallakh
YGYonglin Gao
Yonglin Gao
RRR. Jeannie Roberts
R. Jeannie Roberts

20 May 2008 in Psychiatric Quarterly
Verified
Journal Article
Closed access
PDF file
RERif El-Mallakh
Rif El-Mallakh
MHMichael Hollifield
Michael Hollifield

10 April 2019 in Insects
Verified
Journal Article
Open access
PDF file
RERif El-Mallakh
Rif El-Mallakh
KBKanwarjeet S. Brar
Kanwarjeet S. Brar
RYRajashekar Reddy Yeruva
Rajashekar Reddy Yeruva
Cardiac glycosides, cardenolides and bufadienolides, are elaborated by several plant or animal species to prevent grazing or predation. Entomologists have characterized several insect species that have evolved the ability to sequester these glycosides in their tissues to reduce their palatability and, thus, reduce predation. Cardiac glycosides are known to interact with the sodium- and potassium-activated adenosine triphosphatase, or sodium pump, through a specific receptor-binding site. Over the last couple of decades, and since entomologic studies, it has become clear that mammals synthesize endogenous cardenolides that closely resemble or are identical to compounds of plant origin and those sequestered by insects. The most important of these are ouabain-like compounds. These compounds are essential for the regulation of normal ionic physiology in mammals. Importantly, at physiologic picomolar or nanomolar concentrations, endogenous ouabain, a cardenolide, stimulates the sodium pump, activates second messengers, and may even function as a growth factor. This is in contrast to the pharmacologic or toxic micromolar or milimolar concentrations achieved after consumption of exogenous cardenolides (by consuming medications, plants, or insects), which inhibit the pump and result in either a desired medical outcome, or the toxic consequence of sodium pump inhibition.

1 February 2005 in Journal of Affective Disorders
Verified
Journal Article
Closed access
RERif El-Mallakh
Rif El-Mallakh
AKAnoop Karippot
Anoop Karippot